BEURSKENS; Frank

Patent Applications and Registrations

Patent applications and USPTO patent grants for BEURSKENS; Frank.The latest application filed is for "bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereof".

Company Profile

14.12.33

BEURSKENS; Frank - Utrecht NL
Beurskens; Frank - Culemborg NL
Beurskens; Frank - Buffalo NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bispecific Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies And Methods Of Use Thereof App 20220251231 - OOSTINDIE; Simone ; et al.	2022-08-11
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof Grant 11,396,553 - Oostindie , et al. July 26, 2	2022-07-26
Anti-cd37 Antibodies And Anti-cd20 Antibodies, Compositions And Methods Of Use Thereof App 20210371539 - OOSTINDIE; Simone ; et al.	2021-12-02
Dimeric protein with triple mutations Grant 11,180,572 - De Jong , et al. November 23, 2	2021-11-23
Bispecific Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies And Methods Of Use Thereof App 20210355232 - OOSTINDIE; Simone ; et al.	2021-11-18
Antibody Variant Combinations And Uses Thereof App 20210238296 - DE JONG; Rob ; et al.	2021-08-05
Dimeric Protein With Triple Mutations App 20210230301 - DE JONG; Rob N. ; et al.	2021-07-29
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof Grant 11,034,772 - Oostindie , et al. June 15, 2	2021-06-15
Antibody Variants And Uses Thereof App 20210163619 - PARREN; Paul ; et al.	2021-06-03
Polypeptide Variants And Uses Thereof App 20210107988 - OOSTINDIE; Simone ; et al.	2021-04-15
Bispecific Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies And Methods Of Use Thereof App 20210024647 - OOSTINDIE; Simone ; et al.	2021-01-28
Bispecific Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies And Methods Of Use Thereof App 20200291124 - OOSTINDIE; Simone ; et al.	2020-09-17
Antibody variants and uses thereof Grant 10,759,867 - Parren , et al. Sep	2020-09-01
Bispecific Anti-cd37 Antibodies, Monoclonal Anti-cd37 Antibodies And Methods Of Use Thereof App 20200270359 - OOSTINDIE; Simone ; et al.	2020-08-27
Polypeptide Variants And Uses Thereof App 20200181277 - BEURSKENS; Frank ; et al.	2020-06-11
Variants Of Cd38 Antibody And Uses Thereof App 20200165352 - GOEIJ; Bart De ; et al.	2020-05-28
Antibodies And Methods Of Use Thereof In Treatment Of Infectious Disease App 20200123237 - KUIPERS; Annemarie ; et al.	2020-04-23
Variants Of Cd38 Antibody And Uses Thereof App 20200017600 - GOEIJ; Bart De ; et al.	2020-01-16
Polypeptide Variants And Uses Thereof App 20190276549 - DE JONG; Rob ; et al.	2019-09-12
Recombinant IgG4 monovalent antibodies Grant 10,351,629 - Schuurman , et al. July 16, 2	2019-07-16
Anti-death Receptor Antibodies And Methods Of Use Thereof App 20190202926 - BEURSKENS; Frank ; et al.	2019-07-04
Recombinant Monovalent Antibodies And Methods For Production Thereof App 20190169298 - PARREN; Paul ; et al.	2019-06-06
Recombinant monovalent antibodies and methods for production thereof Grant 10,155,816 - Parren , et al. Dec	2018-12-18
Transgenic Animals Producing Monovalent Human Antibodies And Antibodies Obtainable From These Animals App 20170037138 - SCHUURMAN; Janine ; et al.	2017-02-09
Recombinant IgG4 monovalent antibodies Grant 9,322,035 - Schuurman , et al. April 26, 2	2016-04-26
Human Igg1 Fc Region Variants And Uses Thereof App 20150353636 - PARREN; Paul ; et al.	2015-12-10
Dimeric Protein With Triple Mutations App 20150175707 - De Jong; Rob N. ; et al.	2015-06-25
Antibody Variants And Uses Thereof App 20140242075 - Parren; Paul ; et al.	2014-08-28
Fusion Or Linked Proteins With Extended Half Life App 20110045007 - Schuurman; Janine ; et al.	2011-02-24
Non-glycosylated Recombinant Monovalent Antibodies App 20100325744 - Schuurman; Janine ; et al.	2010-12-23
Transgenic Animals Producing Monovalent Human Antibodies And Antibodies Obtainable From These Animals App 20100306867 - Schuurman; Janine ; et al.	2010-12-02
Method For Extending The Half-life Of Exogenous Or Endogenous Soluble Molecules App 20100291023 - Schuurman; Janine ; et al.	2010-11-18
Method and apparatus for pricing a commodity Grant 7,827,083 - Beurskens November 2, 2	2010-11-02
Recombinant Fucose Modified Monovalent Half-antibodies Obtained By Molecular Engineering App 20100255012 - Schuurman; Janine ; et al.	2010-10-07
System And Method For Providing Recipes On A Scale App 20100000801 - Smith; Richard E. ; et al.	2010-01-07
Recombinant Monovalent Antibodies And Methods For Production Thereof App 20090226421 - Parren; Paul ; et al.	2009-09-10
Methods for treating disorders involving monocytes App 20090155204 - Beurskens; Frank ; et al.	2009-06-18
Method And Apparatus For Pricing A Commodity App 20070130058 - Beurskens; Frank	2007-06-07
Method and apparatus for pricing a commodity Grant 7,200,572 - Beurskens April 3, 2	2007-04-03
Methods for treating disorders involving monocytes App 20050123542 - Beurskens, Frank ; et al.	2005-06-09
Method and apparatus for pricing a commodity App 20050114252 - Beurskens, Frank	2005-05-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.